Skip to content

Application Research of cyclopofol in in Frail Patients Undergoing Major Orthopedic Surgery

Application Research of cyclopofol in in Frail Patients Undergoing Major Orthopedic Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099562
Enrollment
Unknown
Registered
2025-03-25
Start date
2024-11-04
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease, chronic obstructive pulmonary disease, femoral head necrosis, femoral neck fracture

Interventions

ciprofol group(B group):Administer cyclosporine injection at a dose of 0.3mg/kg.
Propofol group(A group):Administer propofol injection at a dose of 2mg/kg.

Sponsors

The First Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients =65 years old (male or female); 2. The American Society of Anesthesiologists(ASA)grades are ?-?; 3. Patients undergoing major orthopaedic surgery with faltering index (mFI) =0.27;

Exclusion criteria

Exclusion criteria: 1. Known allergy to eggs, soy products or experimental drugs (propofol, cyclopofol), opioids, etc.; 2. Patients with multiple injuries combined with other operations; 3. History of long-term use of psychotropic drugs, cognitive dysfunction, active psychiatric disease; 4. Severe cardiovascular system disease, severe respiratory disease; 5. History of substance abuse, drug use, alcohol abuse; 6. Refused to sign the informed consent. 7. Preoperative measurement of hemodynamic instability in patients using ICON measuring instrument;

Design outcomes

Primary

MeasureTime frame
Cardiac output;mean arterial pressure;

Secondary

MeasureTime frame
Wake up extubation time;Usage of vasoactive drugs;postoperative complication;hospital stay;

Countries

China

Contacts

Public ContactShen Xu

The First Hospital of Jiaxing

fishsx0321@sina.com+86 573 83599078

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026